Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
valuation ratios | |
|---|---|
| pe ratio | -0.00 |
| peg ratio | -0.00 |
| price to book ratio | -0.00 |
| price to sales ratio | 0.01 |
| enterprise value multiple | -536.81 |
| price fair value | -0.00 |
profitability ratios | |
|---|---|
| gross profit margin | 79.73% |
| operating profit margin | -21.01% |
| pretax profit margin | -263.21% |
| net profit margin | -227.75% |
| return on assets | -322.92% |
| return on equity | 485.8% |
| return on capital employed | 17.07% |
liquidity ratio | |
|---|---|
| current ratio | 0.22 |
| quick ratio | 0.15 |
| cash ratio | 0.04 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 219.78 |
| operating cycle | 248.78 |
| days of payables outstanding | 154.61 |
| cash conversion cycle | 94.17 |
| receivables turnover | 12.59 |
| payables turnover | 2.36 |
| inventory turnover | 1.66 |
debt and solvency ratios | |
|---|---|
| debt ratio | 2.40 |
| debt equity ratio | -1.05 |
| long term debt to capitalization | -0.02 |
| total debt to capitalization | 19.30 |
| interest coverage | -0.74 |
| cash flow to debt ratio | -0.14 |
cash flow ratios | |
|---|---|
| free cash flow per share | -22.07 |
| cash per share | 7.54 |
| operating cash flow per share | -21.86 |
| free cash flow operating cash flow ratio | 1.01 |
| cash flow coverage ratios | -0.14 |
| short term coverage ratios | -0.14 |
| capital expenditure coverage ratio | -102.84 |
Frequently Asked Questions
Acorda Therapeutics, Inc. (ACOR) published its most recent earnings results on 14-05-2024.
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Acorda Therapeutics, Inc. (NASDAQ:ACOR)'s trailing twelve months ROE is 485.8%.
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Acorda Therapeutics, Inc. (ACOR) currently has a ROA of -322.92%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
ACOR reported a profit margin of -227.75% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
Apple's current ratio, which measures its ability to pay short-term obligations, was 0.22 in the most recent quarter. The quick ratio stood at 0.15, with a Debt/Eq ratio of -1.05.